G7 Therapeutics
G7 Therapeutics is focused on stabilizing GPCRs for the discovery of novel medicines.
Launch date
Employees
Market cap
-
Enterprise valuation
$11m (Public information from Nov 2016)
Zurich Canton of Zürich (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Spinout | |
CHF12.0m Valuation: CHF12.0m | Acquisition | ||
| Total Funding | - | ||